Recently, fused in sarcoma/translated in liposarcoma (FUS/TLS) gene, located on chromosome 16p11.2, has been identified as a disease gene in familial amyotrophic lateral sclerosis (FALS). We have analyzed FUS/TLS in a cohort of 52 index cases from seven Italian regions with non-SOD1 and non-TARDBP FALS. We identified a heterozygous c.G1542C missense mutation in a family of northern Italian origin, and a heterozygous c.C1574T missense mutation in a family of Sicilian origin. Both variants are located in exon 15 encoding the RNA-recognition motif, and result in a substitution of an arginine with a serine in position 514 (p.R514S) and substitution of a proline with a leucine at position 525 (p.P525L), respectively. Overall, the two mutations accounted for 3.8% of 52 non-SOD1 and non-TDP43 index cases of FALS. The clinical phenotype was similar within each of the families, with a predominantly upper limb onset in the family carrying the p.R514S mutation and bulbar onset, with very young age and a rapid course in the family carrying the p.P525L mutation.
Chiò A,, Restagno G,, Brunetti M,, Ossola I, ., Calvo, A., Mora, G., et al. (2009). Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. NEUROBIOLOGY OF AGING, 30(8), 1272-1275 [10.1016/j.neurobiolaging.2009.05.001].
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation
LA BELLA, Vincenzo;SPATARO, Rossella
2009-01-01
Abstract
Recently, fused in sarcoma/translated in liposarcoma (FUS/TLS) gene, located on chromosome 16p11.2, has been identified as a disease gene in familial amyotrophic lateral sclerosis (FALS). We have analyzed FUS/TLS in a cohort of 52 index cases from seven Italian regions with non-SOD1 and non-TARDBP FALS. We identified a heterozygous c.G1542C missense mutation in a family of northern Italian origin, and a heterozygous c.C1574T missense mutation in a family of Sicilian origin. Both variants are located in exon 15 encoding the RNA-recognition motif, and result in a substitution of an arginine with a serine in position 514 (p.R514S) and substitution of a proline with a leucine at position 525 (p.P525L), respectively. Overall, the two mutations accounted for 3.8% of 52 non-SOD1 and non-TDP43 index cases of FALS. The clinical phenotype was similar within each of the families, with a predominantly upper limb onset in the family carrying the p.R514S mutation and bulbar onset, with very young age and a rapid course in the family carrying the p.P525L mutation.File | Dimensione | Formato | |
---|---|---|---|
Neurobiol Aging - 2009.pdf
accesso aperto
Descrizione: articolo principale
Dimensione
427.53 kB
Formato
Adobe PDF
|
427.53 kB | Adobe PDF | Visualizza/Apri |
Neurobiol Aging - 2009.pdf
accesso aperto
Dimensione
427.53 kB
Formato
Adobe PDF
|
427.53 kB | Adobe PDF | Visualizza/Apri |
FUS 1 online.pdf
Solo gestori archvio
Dimensione
270.56 kB
Formato
Adobe PDF
|
270.56 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.